StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Each row shows where SMG sits in our scored universe today on a single observational measurement. P85 means SMG ranks above 85% of peers on that factor right now. Percentile rankings are descriptive — they are not buy/sell signals or quality judgments. Universe refreshed every 60 seconds.
Today's volume vs prior session average.
Absolute daily price move vs peers.
24h article count relative to the universe.
AI-classified polarity of recent news.
Today's dollar turnover (volume × VWAP).
Signed daily return vs the rest of the universe.
Stonvex publishes percentile measurements as observational data only. Nothing here constitutes a recommendation, prediction, or advice about whether to buy, sell, or hold any security. Stonvex is not a registered investment advisor.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $60.99 | $60.03 | -1.57% | 1.4M |
| 05-12 | $59.89 | $59.57 | -0.53% | 1.0M |
| 05-13 | $59.29 | $58.81 | -0.81% | 1.2M |
| 05-14 | $59.54 | $59.04 | -0.84% | 0.5M |
| 05-15 | $58.29 | $56.63 | -2.85% | 0.8M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat. Over half of revenue typically comes from Home Depot and Lowe's, as Scotts' products are featured at both home improvement retailers.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-30 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.81B | $354.40M | $3.41B | $3.03B |
Operating Income | $380.00M | $-21.80M | $358.60M | $508.70M |
Net Income | $113.60M | $-125.00M | $145.20M | $297.10M |
EPS (Diluted) | $1.93 | $-2.16 | $2.47 | $5.07 |
Total Assets | $3.41B | $3.03B | $2.74B | $3.09B |
Total Liabilities | $3.70B | $3.53B | $3.10B | $3.26B |
Cash & Equivalents | $6.20M | $8.30M | $32.80M | $51.10M |
Free Cash Flow OCF − CapEx | $-189.00M | $-390.40M | $273.90M | $142.70M |
Shares Outstanding | 58.20M | 58.00M | 57.80M | 57.70M |